医学
肝细胞癌
血液学
重症监护医学
阶段(地层学)
内科学
肿瘤科
疾病
癌症
肝癌
古生物学
生物
作者
Diwakar Suresh,Akshatha N. Srinivas,Akila Prashant,Kuzhuvelil B. Harikumar,Divya P. Kumar
标识
DOI:10.1007/s10238-023-01014-3
摘要
Hepatocellular carcinoma (HCC) is a chronic liver disease that is highly fatal if not detected and treated early. The incidence and death rate of HCC have been increasing in recent decades despite the measures taken for preventive screening and effective diagnostic and treatment strategies. The pathophysiology of HCC is multifactorial and highly complex owing to its molecular and immune heterogeneity, and thus the gap in knowledge still precludes making choices between viable therapeutic options and also the development of effective regimens. The treatment of HCC demands multidisciplinary approaches and primarily depends on tumor stage, hepatic functional reserve, and response to treatment by patients. Although curative treatments are limited but critical in the early stages of cancer, there are numerous palliative treatments available for patients with intermediate and advanced-stage HCC. In recent times, the use of combination therapy has succeeded over the use of monotherapy in the treatment of HCC by achieving effective tumor suppression, increasing survival rate, decreasing toxicity, and also aiding in overcoming drug resistance. This work focuses on reviewing the current and emerging treatment strategies for HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI